Free Trial

Vertex Pharmaceuticals (VRTX) News Today

Vertex Pharmaceuticals logo
$447.76 +1.76 (+0.39%)
As of 10:55 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VRTX Latest News

Vertex Pharmaceuticals Incorporated stock logo
TFR Capital LLC. Makes New $1.84 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
TFR Capital LLC. purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 4,561 shares of the pharmaceutical
Vertex Pharmaceuticals Incorporated stock logo
Employees Retirement System of Texas Grows Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Employees Retirement System of Texas raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 121,600 shares of the pharmaceutical
Vertex Pharmaceuticals Incorporated stock logo
Jefferies Financial Group Inc. Sells 18,659 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Jefferies Financial Group Inc. trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 57.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,984 shares of the pharma
Vertex Pharmaceuticals Incorporated stock logo
Siemens Fonds Invest GmbH Sells 1,648 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Siemens Fonds Invest GmbH cut its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 13.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,919 shares of the pharmaceutical comp
Vertex Pharmaceuticals Incorporated stock logo
Universal Beteiligungs und Servicegesellschaft mbH Takes Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor p
Vertex Pharmaceuticals Incorporated stock logo
B. Riley Wealth Advisors Inc. Has $2.87 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
B. Riley Wealth Advisors Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 20.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,115 shares of the pharmaceutical company's stock after
Vertex Pharmaceuticals Incorporated stock logo
892 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Acquired by Armis Advisers LLC
Armis Advisers LLC bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 892 shares of the pharmaceutical company's stock, valued at approxim
Vertex Pharmaceuticals Incorporated stock logo
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Great Valley Advisor Group Inc.
Great Valley Advisor Group Inc. raised its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 12.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,593 shares of the phar
Vertex Pharmaceuticals Incorporated stock logo
Integrated Advisors Network LLC Has $1.24 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Integrated Advisors Network LLC decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 17.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,080 shares of the pharmaceuti
Vertex Pharmaceuticals Incorporated stock logo
Mackenzie Financial Corp Lowers Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Mackenzie Financial Corp lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 33.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 45,632 shares of the pharmaceutical company's stock after sel
Vertex Pharmaceuticals Incorporated stock logo
Toronto Dominion Bank Decreases Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Toronto Dominion Bank decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 19.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,834 shares of t
Vertex Pharmaceuticals Incorporated stock logo
Polar Asset Management Partners Inc. Invests $22.95 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Polar Asset Management Partners Inc. bought a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 57,000 shares of the pharmaceutical company's sto
Vertex Pharmaceuticals Incorporated stock logo
Putney Financial Group LLC Purchases New Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Putney Financial Group LLC purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 955 shares of the pharmaceutical company's stock, valued at a
Vertex Pharmaceuticals Incorporated stock logo
Vise Technologies Inc. Grows Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Vise Technologies Inc. raised its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 141.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,809 shares of the p
Vertex Pharmaceuticals Incorporated stock logo
Sunbelt Securities Inc. Sells 646 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Sunbelt Securities Inc. decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 38.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,035 shares of the pharmaceutical compa
Vertex Pharmaceuticals Incorporated stock logo
Montchanin Asset Management LLC Sells 1,620 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Montchanin Asset Management LLC decreased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 14.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,802 shares of
Vertex Pharmaceuticals Q1 Earnings Transcript
Vertex Pharmaceuticals Incorporated stock logo
GF Fund Management CO. LTD. Takes $23.83 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
GF Fund Management CO. LTD. acquired a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 59,178 shares of the
Vertex Pharmaceuticals Incorporated stock logo
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Public Employees Retirement System of Ohio
Public Employees Retirement System of Ohio decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.0% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 115,847 shares of the pharmaceutical company's stock
Vertex Pharmaceuticals Incorporated stock logo
GTS Securities LLC Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
GTS Securities LLC lessened its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 54.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,329 shares of the pharmaceutical company's stock after sel
Vertex Pharmaceuticals Incorporated stock logo
Two Sigma Investments LP Trims Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Two Sigma Investments LP lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 79.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 33,160 shares of the pharmaceutical company's stock after selling 127,375 shar
Vertex Pharmaceuticals Incorporated stock logo
Investment Management Corp VA ADV Takes Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Investment Management Corp VA ADV purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 838 shares of the pharmaceutical company's st
Vertex Pharmaceuticals Incorporated stock logo
Breed s Hill Capital LLC Takes $498,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Breed s Hill Capital LLC purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,236 shares of the pharmaceutical
Vertex Pharmaceuticals Incorporated stock logo
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Waverly Advisors LLC
Waverly Advisors LLC increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 632.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,948 shares of the pharmaceu
Vertex Pharmaceuticals Incorporated stock logo
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by JT Stratford LLC
JT Stratford LLC decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 55.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,956 shares of the pharmaceutical company's st
Vertex Pharmaceuticals Incorporated stock logo
Harmony Asset Management LLC Has $2.53 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Harmony Asset Management LLC cut its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 9.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,275 shares of the pharmaceutical company's stock
Vertex Pharmaceuticals Incorporated stock logo
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Voloridge Investment Management LLC
Voloridge Investment Management LLC reduced its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 49.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 69,712 shares of the pharmaceu
Vertex Pharmaceuticals Incorporated stock logo
Castleark Management LLC Sells 36,240 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Castleark Management LLC trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 43.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 46,485 shares of the pharmaceutical company's stock
Vertex Pharmaceuticals Incorporated stock logo
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 195.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 127,324 shares
Vertex Pharmaceuticals Incorporated stock logo
USS Investment Management Ltd Sells 2,996 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
USS Investment Management Ltd reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 44,403 shares of the pharmaceutical company's stock after
Vertex Pharmaceuticals Incorporated stock logo
Zurich Insurance Group Ltd FI Reduces Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Zurich Insurance Group Ltd FI trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,5
Vertex Pharmaceuticals Incorporated stock logo
Westwood Holdings Group Inc. Makes New $1.28 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Westwood Holdings Group Inc. purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,165 shares of
Vertex Pharmaceuticals Incorporated stock logo
Principal Street Partners LLC Cuts Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Principal Street Partners LLC trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 25.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,258 shares of the pharmaceutical co
Vertex Pharmaceuticals Incorporated stock logo
Lantern Wealth Advisors LLC Buys 650 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Lantern Wealth Advisors LLC boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 72.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,550 shares of
Vertex Pharmaceuticals Incorporated stock logo
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,329,219 shares o
Vertex Pharmaceuticals Incorporated stock logo
Woodline Partners LP Acquires 16,653 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Woodline Partners LP raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 12.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 149,418 shares of the pharmaceutical
Vertex Pharmaceuticals Incorporated stock logo
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Vident Advisory LLC
Vident Advisory LLC raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 137.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 19,834 shares of the pharmaceutical c
Vertex Pharmaceuticals Incorporated stock logo
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Holdings Lifted by Tidal Investments LLC
Tidal Investments LLC lifted its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 57.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,353 shares of
Vertex Pharmaceuticals Incorporated stock logo
Westport Asset Management Inc. Takes Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Westport Asset Management Inc. bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,500 shares
Vertex Pharmaceuticals Incorporated stock logo
Triglav Skladi D.O.O. Takes $1.39 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Triglav Skladi D.O.O. bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 3,450 shares of the pharmaceutical
Vertex Pharmaceuticals Incorporated stock logo
Twinbeech Capital LP Purchases New Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Twinbeech Capital LP purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 55,249 shares of the pharmaceutical company's stock, valued at approximately
Vertex Pharmaceuticals Incorporated stock logo
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Silvercrest Asset Management Group LLC
Silvercrest Asset Management Group LLC grew its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 24.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,348 shares of the pharmaceutical company's
Vertex Pharmaceuticals Incorporated stock logo
Tema Etfs LLC Takes $4.42 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Tema Etfs LLC acquired a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,981 shares of the pharmaceutica
Vertex Pharmaceuticals Incorporated stock logo
Toronto Dominion Bank Has $43.42 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Toronto Dominion Bank trimmed its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 19.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 107,834 shares of
Vertex Pharmaceuticals Incorporated stock logo
Snowden Capital Advisors LLC Has $1.91 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Snowden Capital Advisors LLC decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 58.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,740 shares of the pharmaceutica
Get Vertex Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter.

VRTX Media Mentions By Week

VRTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VRTX
News Sentiment

1.55

1.03

Average
Medical
News Sentiment

VRTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VRTX Articles
This Week

35

27

VRTX Articles
Average Week

Get Vertex Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:VRTX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners